SoftBank Posts Significant Profit Surge Fueled by AI Investment Returns HWH International HWH Gains 388 Support Holds at 100 20260518 US Consumers Face 45 Billion Oil Price Burden Since Iran Conflict Began Oil Price Update How Crude Oil Movements Are Shaping Energy Costs and Consumer Prices in Mid2026 Veeva Systems VEEV Stock Analysis 115 Loss Key Levels 20260520 Range RANG Q1 2026 In Line Where Does Growth Come From Next Cellectis CLLS Reports Strong Q1 2026 Revenue NA EPS Beats Meta Layoffs Signal Tough Choices Ahead as Zuckerberg Warns Success Isnt a Given in AI Race SpaceX IPO Filing Highlights Starlink as Key Profit Engine Ahead of Potential Nasdaq Listing Waymo Halts Robotaxi Operations in Five US Cities Following Incident in Flooded Roads Marvell Faces High Expectations as Wall Street Bets on AIDriven Growth for Upcoming Earnings SEC Postpones Decision on Tokenized Stock Exemption Crypto Market Reacts Oil Prices Decline on Optimism Over Potential USIran Peace Deal Strait of Hormuz Reopening Modine Manufacturing Q4 Results Operational Highlights and Market Outlook DuPont Q1 2026 Earnings EPS Surprise Lifts Shares KUST Q4 2025 Earnings Wide EPS Miss Sinks Estimates Stock Unexpectedly Rises 424 Points WLFC Q1 2026 Earnings EPS Surges Past Estimates by 354 as Leasing Momentum Builds ULH Q1 2026 Earnings A Significant Earnings Miss Amidst Operational Headwinds RUM Q1 2026 Earnings EPS Misses Estimates Stock Gains as Platform Expands Qualcomm Stock Surges as Investors Eye AI Device Boom Burford Capital Q1 2026 Earnings Substantial EPS Miss Reflects Volatility in Litigation Finance Teck Resources TECK Q1 2026 Earnings Commodity Strength Powers Massive EPS Beat OFS Q1 2026 Earnings Massive EPS Beat Driven by Strong Portfolio Performance Sachem Capital Corp SCCF Q4 2025 Earnings EPS Surges Past Estimates Notes Edge Higher ClearOne Inc CLRO Q2 2018 Earnings EPS Surprise Drives Stock Gain Amid Revenue Silence iBio Q1 2026 Earnings EPS Miss Amid PreRevenue Stage Stock Rises 33 CPHI Q3 2011 Earnings EPS Falls Short of Consensus Amid Operational Headwinds Protara Therapeutics Q1 2026 Earnings EPS Beat Despite No Revenue Stock Declines